GlassScriptPhysician profile
Gregory James Blair
NPI 1104269117
$1,036.65
in general payments reported to CMS, 2019-2025
9 companies · $483 in 2025
The $483 reported for 2025 was more than what 83% of Critical Care Medicine (Anesthesiology) providers received nationally (typical 2025 total: $97.90).
See the full distribution for Critical Care Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.00 · 2022: $177 · 2023: $250 · 2024: $116 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $504 · Consulting Fee: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $504.05 |
| Consulting Fee | $345.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $411.87 | 2025 | Nellcor, Corevalve Evolut R |
| Edwards Lifesciences Corporation | $396.95 | 2022-2025 | Sapien 3 Ultra Resilia |
| Takeda Pharmaceuticals U.S.A., INC. | $62.35 | 2024 | Fruzaqla |
| Abbott Laboratories | $38.18 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Myriad Genetic Laboratories, INC. | $36.32 | 2023-2024 | Myrisk, Mychoice Cdx |
| Springworks Therapeutics, INC. | $28.57 | 2025 | Ogsiveo |
| Pharmacosmos Therapeutics INC. | $25.94 | 2023 | Monoferric |
| Iovance Biotherapeutics, INC. | $25.47 | 2025 | Amtagvi |
| Regeneron Healthcare Solutions, INC. | $11.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Blair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.